Literature DB >> 17548651

Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury.

Tobias Eckle1, Lars Füllbier, Manfred Wehrmann, Joseph Khoury, Michel Mittelbronn, Juan Ibla, Peter Rosenberger, Holger K Eltzschig.   

Abstract

Acute lung injury (ALI), such as that which occurs with mechanical ventilation, contributes to morbidity and mortality of critical illness. Nonetheless, in many instances, ALI resolves spontaneously through unknown mechanisms. Therefore, we hypothesized the presence of innate adaptive pathways to protect the lungs during mechanical ventilation. In this study, we used ventilator-induced lung injury as a model to identify endogenous mechanisms of lung protection. Initial in vitro studies revealed that supernatants from stretch-induced injury contained a stable factor which diminished endothelial leakage. This factor was subsequently identified as adenosine. Additional studies in vivo revealed prominent increases in pulmonary adenosine levels with mechanical ventilation. Because ectoapyrase (CD39) and ecto-5'-nucleotidase (CD73) are rate limiting for extracellular adenosine generation, we examined their contribution to ALI. In fact, both pulmonary CD39 and CD73 are induced by mechanical ventilation. Moreover, we observed pressure- and time-dependent increases in pulmonary edema and inflammation in ventilated cd39(-/-) mice. Similarly, pharmacological inhibition or targeted gene deletion of cd73 was associated with increased symptom severity of ventilator-induced ALI. Reconstitution of cd39(-/-) or cd73(-/-) mice with soluble apyrase or 5'-nucleotidase, respectively, reversed such increases. In addition, ALI was significantly attenuated and survival improved after i.p. treatment of wild-type mice with soluble apyrase or 5'-nucleotidase. Taken together, these data reveal a previously unrecognized role for CD39 and CD73 in lung protection and suggest treatment with their soluble compounds as a therapeutic strategy for noninfectious ALI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548651     DOI: 10.4049/jimmunol.178.12.8127

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  137 in total

Review 1.  Endothelial nanomedicine for the treatment of pulmonary disease.

Authors:  Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2014-11-14       Impact factor: 6.648

2.  Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury.

Authors:  Ulrich Schingnitz; Katherine Hartmann; Christopher F Macmanus; Tobias Eckle; Stephanie Zug; Sean P Colgan; Holger K Eltzschig
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

Review 3.  Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia.

Authors:  Almut Grenz; Dirk Homann; Holger K Eltzschig
Journal:  Antioxid Redox Signal       Date:  2011-04-11       Impact factor: 8.401

Review 4.  Beneficial and detrimental role of adenosine signaling in diseases and therapy.

Authors:  Hong Liu; Yang Xia
Journal:  J Appl Physiol (1985)       Date:  2015-08-27

5.  Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation.

Authors:  Qian Liu; Jing Li; Joseph Khoury; Sean P Colgan; Juan C Ibla
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

6.  Central role of Sp1-regulated CD39 in hypoxia/ischemia protection.

Authors:  Holger K Eltzschig; David Köhler; Tobias Eckle; Tianqing Kong; Simon C Robson; Sean P Colgan
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

7.  CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis.

Authors:  Andrey Mikhailov; Alice Sokolovskaya; Gennady G Yegutkin; Hanne Amdahl; Anne West; Hideo Yagita; Riitta Lahesmaa; Linda F Thompson; Sirpa Jalkanen; Dmitry Blokhin; John E Eriksson
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats.

Authors:  Zhenjun Tan; Xinlan Li; Ryan C Turner; Aric F Logsdon; Brandon Lucke-Wold; Kenneth DiPasquale; Soon Soeg Jeong; Ridong Chen; Jason D Huber; Charles L Rosen
Journal:  Eur J Pharmacol       Date:  2014-06-13       Impact factor: 4.432

9.  Proximal Tubule CD73 Is Critical in Renal Ischemia-Reperfusion Injury Protection.

Authors:  Sun-Sang J Sung; Li Li; Liping Huang; Jessica Lawler; Hong Ye; Diane L Rosin; Issah S Vincent; Thu H Le; Jing Yu; Nicole Görldt; Jürgen Schrader; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2016-09-14       Impact factor: 10.121

Review 10.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.